Report Overview

The Indian cardiovascular drugs market size stood at XX Billion in 2019 & is projected to reach USD XX Billion by 2028, exhibiting a CAGR OF 5.9%.

The market for CVDs in India is growing rapidly because of the complex lifestyle changes associated with urbanization and the epidemiologic and nutritional transitions that accompany economic development.

The cardiovascular diseases includes disorders of heart & blood vessels especially and includes the life-threatening conditions such as coronary heart disease, hypertension and hyperlipidaemia. Cardiovascular diseases results in conditions such as myocardial infraction i.e. heart attacks and strokes. The age-standardized prevalence of CVD in India per 100,000 people was around XX during the year 2019-2028.

It is noted that the prevalence of heart diseases and stroke in India has increased by XX% from 1990 to 2019. This shows the rising burden of the diseases on India. During the year 2016-19, CVD alone contributed to XX% of the total deaths in India among which, heart disease caused XX% whereas stroke contributed XX% of total deaths. The most prevalent conditions in India include ischemic heart disease, hypertensive heart disease, and cerebrovascular disease. One in 4 deaths in India are now because of CVDs with ischemic heart disease and stroke responsible for >80% of this burden.



Market Drivers

The Indian government spends just 1.2 % of the GDP on the health sector, which is among the lowest in the world. The market drivers for cardiovascular diseases are large population, growing economic prosperity, and the disease burden. The leading medical devices company spends approximately XX% in R&D as percentage ratio to sales.The growth of the cardiovascular devices market is primarily attributed to the increasing acquisitions and collaboration activities and increasing rate of obesity.On the other hand, growth opportunities in the developing nations and declining prices of coronary stents are likely to have a positive impact on the growth of the Asia Pacific cardiovascular devices market in the coming years. The technological advancements are leading to increasing adoption of the pacemakers, and one of the recent advancements include the development of a leadless pacemaker that is one-tenth the size of the predecessor devices by Medtronic.